This activity is supported by an unrestricted educational grant from Alcon Vision, Johnson & Johnson Vision, and Orasis Pharmaceuticals
Upon completion of this activity, the participant should be able to:
Jointly Proviced by Evolve Medical Education and The Fundingsland Group
ACCREDITATION STATEMENT
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Evolve Medical Education LLC (Evolve) and The Fundingsland Group. Evolve is accredited by the ACCME to provide continuing medical education for physicians.
DESIGNATION STATEMENT
Evolve designates this enduring material for a maximum of .50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Course Viewing Requirements
Supported Browsers:
Internet Explorer 11 for Windows
Edge (recent versions; Chromium-based) for Windows
Google Chrome (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Mozilla Firefox (recent versions) for Windows, Mac OS, iOS, Android, or Linux
Safari (recent versions) for Mac OSX, or iOS
Hardware Requirements:
4GB+ RAM
Recommended internet speed 5Mbps+
Cathleen M. McCabe, MD
Chief Medical Officer, Eye Health America
Medical Director, The Eye Associates
Bradenton, FL
Iqbal Ike K. Ahmed, MD
Assistant Professor, University of Toronto
Fellowship Director, Glaucoma and Anterior Segment Surgery Fellowship, University of Toronto
Research Director, Kensington Eye Institute, University of Toronto
Division Head, Ophthalmology, Trillium Health Partners, Mississauga, Ontario
Medical Director, Prism Eye Institute
Co-Medical Director, TLC Oakville
Toronto, Canada
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.
The following faculty/staff members have the following financial relationships with commercial interests:
Cathleen M. McCabe, MD, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Alcon Vision, Allergan, Bausch + Lomb, Carl Zeiss Meditec, Dompe, Engage Technologies, EyePoint Pharmceuticals, Imprimis, Ivantis, Novartis, Ocular Therapeutix, Omeros, Science Based Health, Sight Sciences and Tarsus. Grant/Research Support: Alcon Vision, Allergan, Bausch + Lomb, EyePoint Pharmceuticals, Glaukos, Ivantis, Johnson & Johnson Vision, Ocular Therapeutix, and Ora. Stock/Shareholder: Engage Technologies.
Iqbal Ike K. Ahmed, MD, had a financial agreement or affiliation during the past year with the following commercial interest in the form of Consultant: Aequus, Aerie Pharmaceuticals, Akorn, Alcon Vision, Allergan, Aquea Health, ArcScan, Bausch Health, Beaver Health, Beaver Visitec, Camras Vision, Carl Zeiss Meditec, CorNeat Vision, Ellex, ELT Sight, ElutiMed, Equinox, Genentech, Glaukos, Gore, InjectSense, Iridex, iStar, Ivantis, Johnson & Johnson Vision, KeLoTec, LayerBio, Leica, Long Bridge Medical, MicroOptx, MST Surgical, Mynosys, New World Medical, Ocular Instruments, Ocular Therapeutix, PolyActiva, Sanoculis, Santen, Science Based Health, Sight Sciences, Smartlens, Stroma, Thea, ViaLase, and Vizzario. Speaker Honoraria: Alcon, Allergan, Carl Zeiss Meditec, Johnson & Johnson Vision, MST Surgical, Mundipharma. Research Grants: Aerie Pharmaceuticals, Alcon Vision, Allergan, Camras, Glaukos, Johnson & Johnson Vision, New World Medical, and Santen.
The Evolve and The Fundingsland Group staff and planners have no financial relationships with commercial interests. Nisha Mukherjee, MD, peer reviewer, has no financial relationships with commercial interests.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, The Fundingsland Group, Alcon Vision, Johnson & Johnson Vision, and Orasis Pharmaceuticals.
